Breaking News Instant updates and real-time market news.

SNY

Sanofi

$46.13

-0.43 (-0.92%)

11:03
10/18/19
10/18
11:03
10/18/19
11:03

Sanofi announces precautionary voluntary recall of Zantac OTC in U.S., Canada

As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac OTC in the U.S. and Canada. This recall is being taken due to possible contamination with a nitrosamine impurity called N-nitrosodimethylamine. The company is working with health authorities to determine the level and extent of the recall. On September 13, 2019, the U.S Food and Drug Administration and Health Canada issued public statements alerting that some ranitidine medicines, including Zantac OTC, could contain NDMA at low levels and asked manufacturers to conduct testing. Evaluations are ongoing on both drug substance and finished drug product. Due to inconsistencies in preliminary test results of the active ingredient used in the U.S. and Canadian products, Sanofi has made the decision to conduct the voluntary recall in the U.S. and Canada as the investigation continues. Active ingredients used in Sanofi's ranitidine products outside of the U.S. and Canada are sourced from different suppliers. Sanofi is committed to transparency and will continue to communicate results with health authorities from the ongoing testing, and work with them to make informed decisions based on available data and evidence. Sanofi encourages anyone using Zantac OTC to speak with their health care providers or pharmacists if they have any additional questions.

  • 19

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Dec

SNY Sanofi
$46.13

-0.43 (-0.92%)

09/23/19
GUGG
09/23/19
UPGRADE
GUGG
Buy
Sanofi upgraded to Buy on Dupixent's accelerating uptake at Guggenheim
Guggenheim analyst Seamus Fernandez upgraded Sanofi (SNY) to Buy from Neutral based on his view that Dupixent's accelerating uptake across Asthma and Atopic Dermatitis, and several other indications, should drive earlier than expected profitability of the Regeneron (REGN) antibody collaboration. He also believes that emerging markets growth should help stabilize the large established products and overall diabetes franchises and thinks that vaccines business growth looks sustainable. Fernandez, who also thinks pipeline expectations seem low, set a EUR96 price target on Sanofi shares.
09/23/19
GUGG
09/23/19
UPGRADE
Target $403
GUGG
Buy
Guggenheim upgrades Regeneron to Buy, says sentiment too negative
As previously reported, Guggenheim upgraded Regeneron (REGN) to Buy from Neutral as analyst Yatin Suneja noted that Eylea has maintained its dominance in the branded anti-VEGF retinal disease market despite "stiff branded competition" from Roche's (RHHBY) Lucentis and off-label use of Roche's Avastin. Eylea's expansion into new indications has resulted in a diversified business and defensible market position, argued Suneja, who also believes the Street is substantially under-appreciating the market opportunity for Dupixent, which is expected to drive significant leverage in the Sanofi (SNY) antibody collaboration that recently became profitable. Suneja raised the price target on Regeneron shares to $403 from $355.
10/02/19
STFL
10/02/19
NO CHANGE
Target $45
STFL
Buy
Stifel remains buyer of Principia Biopharma into Q4 data readouts
Stifel analyst Derek Archila remains bullish and a buyer of Principia Biopharma (PRNB) shares ahead of the company's two Phase 2 readouts for PRN1008 in immune thrombocytopenia and pemphigus vulgaris. The shares could reach the mid-$50 range if results are positive, Archila tells investors in a research note. He believes the bogey for each study is not that high and keeps a Buy rating on Principia with a $45 price target. The two clinical catalysts, coupled with Phase 2 data expected in the first half of 2020 from the company's partnered program with Sanofi (SNY) in multiple sclerosis, offers "multiple shots for valuation creation" over the next nine months.
10/15/19
BOFA
10/15/19
NO CHANGE
BOFA
Europe 1 List changes at BofA/Merrill
BofA/Merrill added Roche (RHHBY) and Sanofi (SNY) to the Europe 1 List and removed AstraZeneca.

TODAY'S FREE FLY STORIES

I

Intelsat

$13.27

-0.13 (-0.97%)

11:48
11/18/19
11/18
11:48
11/18/19
11:48
Hot Stocks
FCC Chair calls for public auction of 280 megahertz of C-band »

FCC Chair Ajit Pai…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AUPH

Aurinia Pharmaceuticals

$5.70

0.48 (9.20%)

11:45
11/18/19
11/18
11:45
11/18/19
11:45
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
11/18/19
11/18
11:45
11/18/19
11:45
General news
Treasury's $87 B 3- and 6-month bill auctions saw solid sponsorship »

Treasury's $87 B 3-…

11:45
11/18/19
11/18
11:45
11/18/19
11:45
General news
Breaking General news story  »

Cleveland Federal Reserve…

WE

We Company

$0.00

(0.00%)

, TMUS

T-Mobile

$77.93

-0.12 (-0.15%)

11:39
11/18/19
11/18
11:39
11/18/19
11:39
On The Fly
T-Mobile's Legere stepping down as CEO, but won't join WeWork »

Shares of T-Mobile (TMUS)…

WE

We Company

$0.00

(0.00%)

TMUS

T-Mobile

$77.93

-0.12 (-0.15%)

S

Sprint

$5.85

0.02 (0.34%)

VZ

Verizon

$59.40

-0.11 (-0.18%)

T

AT&T

$39.32

-0.17 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

  • 30

    Jan

11:37
11/18/19
11/18
11:37
11/18/19
11:37
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

11:37
11/18/19
11/18
11:37
11/18/19
11:37
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

WMT

Walmart

$120.41

1.52 (1.28%)

11:36
11/18/19
11/18
11:36
11/18/19
11:36
Periodicals
Three dead following shooting at Walmart in Duncan, OK, Fox 25 reports »

Officials with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDR

Cloudera

$8.80

0.04 (0.46%)

11:35
11/18/19
11/18
11:35
11/18/19
11:35
Options
Cloudera put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

WMT

Walmart

$120.42

1.53 (1.29%)

11:31
11/18/19
11/18
11:31
11/18/19
11:31
Periodicals
Breaking Periodicals news story on Walmart »

At least three people…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$78.07

0.02 (0.03%)

11:27
11/18/19
11/18
11:27
11/18/19
11:27
Recommendations
T-Mobile analyst commentary  »

T-Mobile CEO transition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

LB

L Brands

$18.05

-0.03 (-0.17%)

11:25
11/18/19
11/18
11:25
11/18/19
11:25
Options
L Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 05

    Dec

ATTO

Atento

$2.83

(0.00%)

11:25
11/18/19
11/18
11:25
11/18/19
11:25
Conference/Events
Atento to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MDCO

The Medicines Co.

$55.12

3.2 (6.16%)

11:25
11/18/19
11/18
11:25
11/18/19
11:25
Conference/Events
The Medicines Co. to host conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

TMUS

T-Mobile

$78.12

0.07 (0.09%)

11:21
11/18/19
11/18
11:21
11/18/19
11:21
Recommendations
T-Mobile analyst commentary  »

Legere's departure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/18/19
11/18
11:17
11/18/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/18/19
11/18
11:16
11/18/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/18/19
11/18
11:15
11/18/19
11:15
General news
Chair Powell met with President Trump and Treasury Secretary Mnuchin »

Chair Powell met with…

11:15
11/18/19
11/18
11:15
11/18/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
11/18/19
11/18
11:15
11/18/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

LK

Luckin Coffee

$28.78

1.72 (6.36%)

11:09
11/18/19
11/18
11:09
11/18/19
11:09
Options
Heavy option volume in Luckin Coffee as display caffeine jitters »

Heavy option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

PTON

Peloton

$28.40

1.12 (4.11%)

11:05
11/18/19
11/18
11:05
11/18/19
11:05
Options
Peloton Interactive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

BA

Boeing

$373.21

1.66 (0.45%)

11:03
11/18/19
11/18
11:03
11/18/19
11:03
Hot Stocks
Boeing 'strongly disagrees' with OIG report conclusions about CST-100 Starliner »

In response to the Nov.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRP

TC Energy

$51.43

0.05 (0.10%)

11:00
11/18/19
11/18
11:00
11/18/19
11:00
Conference/Events
TC Energy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

SPY

SPDR S&P 500 ETF Trust

$311.27

-0.56 (-0.18%)

, SPX

S&P 500

$0.00

(0.00%)

10:53
11/18/19
11/18
10:53
11/18/19
10:53
General news
Trump says negative rates, easing discussed in 'very good' meeting with Powell »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$311.27

-0.56 (-0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.